Edition:
United Kingdom

Prophase Labs Inc (PRPH.OQ)

PRPH.OQ on NASDAQ Stock Exchange Capital Market

2.36USD
23 Feb 2018
Change (% chg)

$-0.03 (-1.26%)
Prev Close
$2.39
Open
$2.36
Day's High
$2.36
Day's Low
$2.35
Volume
3,929
Avg. Vol
1,655
52-wk High
$2.50
52-wk Low
$1.78

Latest Key Developments (Source: Significant Developments)

ProPhase Labs quarterly loss per share $0.05 from continuing operations
Monday, 13 Nov 2017 

Nov 13 (Reuters) - ProPhase Labs Inc :ProPhase Labs reports financial results for the three months and nine months ended September 30, 2017.Quarterly loss per share $0.05 from continuing operations.Quarterly sales $3.0 million versus $1.4 million.  Full Article

Prophase Labs intends to commence tender offer to repurchase up to 1.7 mln shares
Friday, 10 Nov 2017 

Nov 10 (Reuters) - Prophase Labs Inc :Prophase Labs, Inc. announces intention to commence tender offer to repurchase up to 1,700,000 shares of its common stock.Prophase Labs Inc - ‍tender offer at a price per share of $2.30 per share​.Prophase Labs - ‍anticipates tender offer will be launched on or before Nov 20, 2017 and will remain open for at least 20 business days.  Full Article

Prophase Labs reports qtrly shr loss $0.06
Tuesday, 9 Aug 2016 

Prophase Labs Inc says - : Prophase Labs reports financial results for the three months and six months ended June 30, 2016; exploring strategic alternatives to enhance shareholder value . Net sales were $2.8 million for three months ended June 30, 2016 as compared to $2.2 million for three months ended June 30, 2015 . Prophase Labs Inc qtrly loss per share $0.06 . Working with Bourne Partners to assist in strategic review .Says alternatives include possible sale of core assets of company as well as explore a range of potential acquisitions.  Full Article

Prophase Labs reports Q1 loss per share $0.08
Tuesday, 10 May 2016 

Prophase Labs Inc : Prophase labs reports financial results for the three months ended March 31, 2016 . Quarterly loss per share $0.08 .Quarterly sales $5.4 million versus $5.9 million.  Full Article

BRIEF-Prophase Labs Announces New Compensatory Arrangement With CEO And Termination Of Stockholder Rights Plan

* PROPHASE LABS, INC. ANNOUNCES NEW COMPENSATORY ARRANGEMENT WITH CHIEF EXECUTIVE OFFICER AND TERMINATION OF STOCKHOLDER RIGHTS PLAN

No consensus analysis data available.